Two drug makers sanctioned for non-obligation of GMP standards

Published: 2011-03-08 06:56:00
Updated: 2011-03-08 06:56:00
The Korea Food and Drug Administration says it notified MSD Korea and GSK to have two companies suspend the importation of Cozaar Plus-F tablets and Lamictal tablets, respectively, for one month (from May 14 to April 13) due to local distribution of substandard products.

The administration add...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.